Skip to main content

LU F23 (Minocycline Hydrochloride Extended-Release 135 mg)

Pill with imprint LU F23 is Brown, Capsule-shape and has been identified as Minocycline Hydrochloride Extended-Release 135 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Minocycline is used in the treatment of bacterial infection; acne; bartonellosis; actinomycosis; bullous pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LU F23

Minocycline hydrochloride extended-release 135 mg LU F23

Minocycline Hydrochloride Extended-Release

LU F23
135 mg
Prescription only
Drug Class
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
Inactive Ingredients
ferric oxide yellow, hypromelloses, silicon dioxide, microcrystalline cellulose, magnesium stearate, polyethylene glycol, titanium dioxide, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.